Can a Mother's mindset influence her Baby's heart tracing?

NCT ID NCT07774936

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This study looks at whether a pregnant woman's beliefs about her baby's health and her anxiety levels are linked to the results of a common fetal heart monitoring test (non-stress test) in high-risk pregnancies. Researchers will ask women at 32 weeks or later to fill out questionnaires about their health beliefs and anxiety, then compare those answers with their baby's heart rate patterns. The goal is to understand if psychological factors might play a role in how the baby's heart responds during monitoring.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If links are found, it could point toward ways to support high-risk pregnant women—like reducing anxiety—to potentially improve fetal monitoring outcomes.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may be influenced by many factors and may not apply to all high-risk pregnancies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women at 32 weeks of gestation or later who are being followed for a high-risk pregnancy and undergo routine non-stress testing. Participants will complete the Fetal Health Locus of Control Scale and the Beck Anxiety Inventory on the same day as their routine NST.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Singleton pregnancy at 32 weeks of gestation or later * Being followed for a high-risk pregnancy * No known diagnosed psychiatric disorder and no current psychiatric medication use * Absence of a fetal condition considered likely to affect the NST tracing * Maternal age between 18 and 45 years Exclusion Criteria: * Gestational age below 32 weeks and/or multiple pregnancy * Presence of a fetal condition considered likely to affect the NST tracing * Acute maternal infection or an obstetric emergency * Known diagnosed psychiatric disorder and/or current psychiatric medication use * Maternal age below 18 years or above 45 years

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for High risk pregnancy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Istanbul Training and Research Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.